-- ユニバイオサイエンス(香港証券取引所:0690)は、既存の株式オプション制度を廃止し、新たな制度を導入することを提案した。これは木曜日に香港証券取引所に提出された書類で明らかになった。 同社の株価は金曜日の午前中の取引で1%近く下落した。 2016年9月に導入された現行制度は9月に期限切れとなり、新規の付与は停止される。 発表日現在、現行制度に基づく未付与のオプションは4億2060万個となっている。 同社は、新たな制度は、対象となる参加者の貢献に対して引き続きインセンティブと報酬を与えることを目的としていると述べた。
Related Articles
Rothschild & Co Redburn Adjusts Price Target on Otis Worldwide to $101 From $112, Maintains Buy Rating
Otis Worldwide (OTIS) has an average rating of overweight and mean price target of $93.54, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $78.45, Change: $+0.50, Percent Change: +0.64%
NICE Says Bell Integration Selects CXone Platform to Support Service Desk Projects
NICE (NICE) said Monday that information technology services and consultancy Bell Integration has selected its CXone platform to back service desk and business development operations.Initial deployment will be in three sites and will support up to 1,000 employees, the company said.Financial details were not provided.NICE shares were up nearly 2% in morning trading.Price: $102.69, Change: $+2.34, Percent Change: +2.33%
BofA Securities Adjusts Price Target on Western Digital to $495 From $415
Western Digital (WDC) has an average rating of overweight and mean price target of $387.27, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $402.91, Change: $-1.09, Percent Change: -0.27%